Your shopping cart is currently empty

M4K2306 is a selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC50 of 7 nM. It is capable of penetrating the blood-brain barrier, exhibiting a brain-to-plasma ratio of 75.6.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | M4K2306 is a selective inhibitor of activin receptor-like kinase 2 (ALK2) with an IC50 of 7 nM. It is capable of penetrating the blood-brain barrier, exhibiting a brain-to-plasma ratio of 75.6. |
| Targets&IC50 | ALK5:3915 nM, ALK2:7 nM |
| In vivo | Following a single oral dose of M4K2306 (25 mg/kg) in the NOD-SCID mouse model, the plasma concentrations at 1 hour and 24 hours post-administration reached C max values of 254 mM and 17 mM, respectively. |
| Molecular Weight | 474.59 |
| Formula | C28H34N4O3 |
| Cas No. | 3034840-25-7 |
| Smiles | N1=CC(C2=CC(OC)=C(OC)C(OC)=C2)=C3C(=C1)C4=CC=C(C=C4CN(C)C3)N5CCN(C)CC5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.